South African Variant
-
{
- All
- News
-
South African Variant May "Break Through" Pfizer Vaccine Protection, Says Study
The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found.
-
AstraZeneca Could Have Vaccine Against South African Variant By End-2021: Report
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.
-
South African Variant-Specific Vaccine Ready For Testing: Moderna
US biotech firm Moderna said Wednesday that doses of its new Covid-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
-
UK Starting To Restrict Spread Of Covid Variants: Health Secretary
Britain has started to drive down cases of the more infectious South African variant of coronavirus and will only emerge from lockdown in stages to make sure that does not change, the country's health secretary said on Sunday.
-
South African Virus Variant Could Significantly Reduce Vaccine Protection: Pfizer
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
-
South African Variant May "Break Through" Pfizer Vaccine Protection, Says Study
The coronavirus variant discovered in South Africa can break through the protection provided by Pfizer Inc and BioNTech's COVID-19 vaccine to some extent, a real-world data study in Israel found.
-
AstraZeneca Could Have Vaccine Against South African Variant By End-2021: Report
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.
-
South African Variant-Specific Vaccine Ready For Testing: Moderna
US biotech firm Moderna said Wednesday that doses of its new Covid-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
-
UK Starting To Restrict Spread Of Covid Variants: Health Secretary
Britain has started to drive down cases of the more infectious South African variant of coronavirus and will only emerge from lockdown in stages to make sure that does not change, the country's health secretary said on Sunday.
-
South African Virus Variant Could Significantly Reduce Vaccine Protection: Pfizer
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
